Integral Health Asset Management’s ChemoCentryx, Inc. CCXI Stock Holding History

Integral Health Asset Management’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-574,029	Closed	-$14.2M	–	87
2022 Q2	$14.2M	Buy	574,029 +174,029	+44%	+$3.84M	2.93%	9
2022 Q1	$10M	Buy	400,000 +200,000	+100%	+$5.62M	2.61%	10
2021 Q4	$7.28M	Sell	200,000 -100,000	-33%	-$3.51M	2.02%	18
2021 Q3	$5.13M	Buy	300,000 +125,000	+71%	+$1.95M	1.47%	24
2021 Q2	$2.34M	Buy	175,000 +20,000	+13%	+$493K	0.65%	46
2021 Q1	$7.94M	Sell	155,000 -25,000	-14%	-$1.5M	2.27%	15
2020 Q4	$11.1M	Sell	180,000 -5,000	-3%	-$286K	3.32%	7
2020 Q3	$10.1M	Buy	185,000 +35,000	+23%	+$1.88M	3.1%	7
2020 Q2	$8.63M	Sell	150,000 -40,000	-21%	-$2.18M	2.58%	10
2020 Q1	$7.63M	Buy	190,000 +140,000	+280%	+$5.94M	3.36%	9
2019 Q4	$1.98M	Buy	+50,000	New	+$878K	0.77%	37

Other funds holding CCXI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

SFM

Soros Fund Management New York $9.12B AUM 30.69% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Integral Health Asset Management's CCXI Position: Q3 2022 in Review

Integral Health Asset Management sold out of ChemoCentryx, Inc. (CCXI) in Q3 2022, closing a stake of 574,029 shares — an estimated $14.2M sold.

Integral Health Asset Management first reported a position in CCXI in Q4 2019 and held it in 11 quarters. The position peaked at $14.2M in Q2 2022. 217 funds tracked by Wall St. Rank hold CCXI as of Q3 2022.

Integral Health Asset Management reported no remaining ChemoCentryx, Inc. position as of Q3 2022 after selling out during the quarter.
Integral Health Asset Management sold 574,029 ChemoCentryx, Inc. shares in Q3 2022, an estimated $14.2M.
Integral Health Asset Management first reported a position in ChemoCentryx, Inc. in Q4 2019 and held it in 11 quarters.
Integral Health Asset Management's ChemoCentryx, Inc. position peaked at $14.2M in Q2 2022.
217 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q3 2022.

Based on Integral Health Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.